Minorities represent an increasing segment of the United States population, with the largest groups in the 2010 United States Census being Hispanics (16.3%), African-Americans (12.6%), and Asians (4.8%) 1 . Moreover, the United States census data reveal that more than one-half of the total growth of the United States population from 2000 to 2010 was attributed to the increase in the Hispanic population 1 . The current literature suggests that racial and ethnic differences may have an important impact on the outcomes of orthopaedic patients [2] [3] [4] [5] [6] [7] [8] [9] [10] . For this reason, the appropriate reporting of race and ethnicity in orthopaedic studies appears crucial. The clinical utility of study data depends on the extent to which the data are generalizable 11 . Failure to report the race and ethnicity of patients in clinical trials can limit the confidence with which clinicians can apply published results to their specific racial and ethnic patient cohort.
The National Institutes of Health (NIH) Revitalization Act of 1993 mandated that clinical trials receiving federal funding provide an analysis of results according to race and ethnicity 12 . However, adherence to this regulation in other fields of medicine has been poor [13] [14] [15] [16] [17] [18] . To the best of our knowledge, the reporting of race and ethnicity in orthopaedic randomized controlled trials (RCTs) has not been investigated. The objective of this study was to answer the following questions: (1) What is the rate of reporting of race and/or ethnicity demographic data in orthopaedic RCTs from the United States? (2) Among studies reporting race/ ethnicity, what is the racial and ethnic distribution of patients?
Materials and Methods
We performed a comprehensive systematic literature review to investigate the inclusion of race and/or ethnicity data across published RCTs in orthopaedic surgery. Our review adhered to the AMSTAR (Assessment of Multiple Systematic Reviews) reporting standards 19 . RCTs of relevance to orthopaedic surgery published from January 2008 to December 2011 were identified by means of a manual search of thirty-two scientific journals. The search was conducted by an orthopaedic expert with experience in medical research; following identification of candidate studies, a secondary review of these studies was conducted by a second researcher and irrelevant trials were excluded upon agreement. Inclusion criteria consisted of (1) a randomized controlled trial design, (2) performance of the study within the field of orthopaedics, and (3) performance of the study within the United States. Multicenter trials were included if their primary study location was within the United States and if at least 80% of the included patients were from the United States. Meta-analyses were not included. For the purposes of this work, definitions of race and ethnicity were taken from the Office of Management and Budget's guidelines for federal data, with race considered a categorical construct (American Indian or Alaskan Native, Asian, Black or African-American, Native Hawaiian or Other Pacific Islander, or White) and ethnicity used to describe Hispanic compared with non-Hispanic origin 20 . Each study was reviewed to assess whether a demographic breakdown according to race and/or ethnicity was reported and which descriptive terms were used. For the studies in which any race and/or ethnicity demographic information was reported, the number of patients in each demographic group was recorded. Any inclusion of demographic race and/or ethnicity data was considered to be a report of such data, regardless of whether the results were stratified by racial or ethnic groups. We also extracted the publication date, start and end year of patient inclusion, study category (fracture, degenerative disease, pain management, pediatrics, or other), study body site (upper extremity, lower-extremity long bones, hip and knee, foot and ankle, or spine), ZIP code of the primary research site, total number of patients, patient age, funding type (industry, government, or other), journal name, and surgical or nonsurgical trial nature. The impact factor of the journal for the year of publication was also identified 21 .
Statistical Analysis
Univariate comparisons were performed for all extracted study variables to determine whether there was a significant difference between studies that reported race and/or ethnicity and those that did not. Continuous data were analyzed with use of the Wilcoxon Mann-Whitney test or Student t test if the data were normally distributed. Discrete variables were analyzed with use of the chi-square test or Fisher exact test, depending on the group size.
Multivariate logistic regression modeling was performed to determine independent predictors of the reporting of race and/or ethnicity. Initially, all variables that were associated with the reporting of race and/or 
LACK O F DIVERSITY I N ORTHOPAEDIC TRIALS CONDUCTED I N T H E UNITED STATES ethnicity at the p < 0.2 level in the univariate analyses were included in the regression analysis. These variables were spine studies, pain studies, government funding, and sample size. In addition, the journal impact factor was included. A stepwise process with backward elimination was then performed, and those variables with a p value of <0.1 were retained in the final regression. The quality of the final stepwise logistic regression model for the prediction of race and/or ethnicity reporting was assessed in terms of calibration with use of the Hosmer-Lemeshow goodness-of-fit test and in terms of discrimination on the basis of the area under the receiver operator characteristic curve (AUC). Calibration is defined as the ability of the regression model to assign the appropriate risk of outcomes among the studies. Discrimination is defined as the ability of the regression model to distinguish between those studies having and those not having the outcomes.
Source of Funding
No external funding was received for this study.
Results

Descriptive Statistics
The manual search resulted in the identification of 685 RCTs. Of these, 158 trials including a total of 37,625 patients were performed in the United States. Thirty-two (20.3%) of these 158 trials reported race and/or ethnicity by means of at least one descriptor. The percentage of Hispanic patients was extractable for trials including 7648 enrolled patients, and the percentage of African-American patients was extractable for trials including 6591 patients. In those studies, 352 (4.6%) of 7648 patients were reported to be Hispanic and 410 (6.2%) of 6591 patients were reported to be African-American. A source of funding was reported in 67.7% of the 158 trials, an absence of external funding was reported in 16.5%, and no funding information was given in 15.8%. The proportions of Hispanics and African-American patients were 3.5-fold and twofold lower, respectively, than those represented in the 2010 United States Census.
Predictors of Better Reporting of Race and/or Ethnicity
Reporting of race and/or ethnicity did not change over time (Fig. 1) . Unadjusted univariate comparisons are shown in Table I (general study information) and Table II (clinical study data). In the univariate analysis, a greater proportion of studies funded by the government (p = 0.003) and by NIH specifically (p = 0.004) reported race and/or ethnicity compared with studies with other funding. The study population was significantly larger in studies reporting race and/or ethnicity (mean and standard deviation, 419 ± 819) compared with studies not reporting such information (192 ± 502, p = 0.01). The mean journal impact factor did not differ significantly between studies reporting race and/or ethnicity (7.2 ± 13.7) and studies not reporting such information (3.1 ± 4.6, p = 0.25). The variables that had a p value of <0.2 and were subsequently used in the multiple regression analysis were spine studies, pain studies, 
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LACK O F DIVERSITY I N ORTHOPAEDIC TRIALS CONDUCTED I N T H E UNITED STATES government funding, and sample size. In addition, the journal impact factor was included in the multiple regression analysis. Given the relatively small number of studies reporting race and/or ethnicity, stepwise logistic regression with backward elimination was used to reduce the number of variables in the model, using an elimination threshold of p = 0.1. The variables included in the final stepwise logistic regression for race and/or ethnicity reporting were pain studies, government funding, sample size, and journal impact factor. Of these, government funding was the only variable identified as a predictor of race and/or ethnicity reporting at the p < 0.05 level (Table  III) . The final regression for the prediction of race and/or ethnicity reporting demonstrated adequate calibration (p = 0.899) and discriminatory power (AUC = 0.734).
Discussion
It has been widely recognized in the orthopaedic literature that racial and ethnic differences have a substantial impact on the management of orthopaedic patients [2] [3] [4] [5] [6] [7] [8] [9] [10] . For instance, morphologic studies have demonstrated racial and ethnic differences in knee anatomy as well as in tibiofemoral arthritis patterns 22, 23 . Orthopaedic outcomes have also been linked to race and ethnicity, with African-American and Hispanic patients having a higher risk of postoperative complications and lower functional outcomes following total hip and total knee replacement 3, 4, 7, 8, 10, 24, 25 . Racial and ethnic health-care disparities with regard to utilization of orthopaedic surgical treatment have also been well described. Compared with non-Hispanic white patients, African-American and Hispanic patients are less likely to undergo total hip and total knee arthroplasty for arthritis treatment [26] [27] [28] . Similar utilization patterns have been observed for other orthopaedic procedures, such as internal fixation of distal radial fractures 29 and reconstruction of anterior cruciate ligament tears 30 . For these reasons, appropriate reporting of patient race and ethnicity appears paramount when interpreting study results. The first primary finding of our study is that the overall rate of reporting of race and/or ethnicity in orthopaedic RCTs from the United States was low (20.3%). The second primary finding is that minorities were strongly underrepresented in these trials, with only 4.6% Hispanics (compared with 16.3% in the United States population) and 6.2% African-Americans (compared with 12.6% in the United States population) 1 . The present study has both strengths and limitations. The RCTs included in our analysis were identified through a manual search of thirty-two journals, including all major orthopaedic journals and five major medical journals. One potential limitation of the study is the risk that additional RCTs were missed because they were published in a different journal. However, we believe that the chances that an orthopaedic RCT from the United States was not published in any of the aforementioned thirty-two scientific journals are minimal. Moreover, the authors of a recent study have emphasized the superior effectiveness of manual search strategies and have pointed out that, even with complex search strategies, electronic searches may miss as much as 18% of published RCTs 31 . Another shortcoming of the study relates to the relatively low percentage of minority e56 (4) T
LACK O F DIVERSITY I N ORTHOPAEDIC TRIALS CONDUCTED I N T H E UNITED STATES patients who were enrolled in orthopaedic RCTs. Given the overall poor rate of reporting race and/or ethnicity across all RCTs, we remain unable to determine the exact proportion of enrolled minority patients. However, the data recorded in our study represent the best available estimation of minority enrollment in orthopaedic RCTs from the United States. Finally, RCTs represent only a small portion of the orthopaedic literature. For this reason, we are unable to draw any conclusions regarding studies with lower levels of evidence. RCTs were chosen in the present study because of the assumption that, as the highest-quality studies, they have the greatest impact on clinical decision-making.
To the best of our knowledge, the reporting of race and ethnicity within the orthopaedic literature has not been investigated and comparable data can only be obtained from other fields of medicine. Hoel et al. explored reporting in United States vascular surgery trials and found that only 21% of RCTs provided data on race and/or ethnicity 16 . Similarly, Frampton et al. found that 26% of published asthma-related RCTs included such data 32 . Data regarding the underrepresentation of minority patients in orthopaedic RCTs are likewise limited in the orthopaedic literature. However, low rates of enrollment of minority patients in clinical trials have also been documented in other fields of medicine [13] [14] [15] [16] [17] [18] 32, 33 . We can only make assumptions about possible reasons for the low enrollment of minority patients in orthopaedic RCTs, but we agree with other investigators that this is most likely a multifactorial problem [34] [35] [36] [37] . Possible reasons include patient-related factors, such as cultural barriers, language barriers, communication barriers, mistrust, concerns about risks, time commitments, transportation issues, family and work responsibilities, financial barriers, and fear of additional costs. Other contributing factors may include investigator-related issues, such as exclusion of non-English-speaking patients by the study design, failure to provide translations of study information and study questionnaires, and failure to enroll minority patients because of concerns about compliance with instructions.
Several suggestions should be considered to increase enrollment of minority patients in orthopaedic RCTs and to improve the reporting of race and ethnicity in the orthopaedic literature. Investigators performing RCTs should consider actively recruiting minority patients for their studies. In particular, principal investigators of multicenter studies should consider including study sites in geographic regions that are accessible to minority patients. Moreover, study designers should consider reducing obstacles to inclusion of minorities, such as providing study information in non-English languages and using outcome measures that are translated into, and validated in, other languages. A notable example from the medical literature is in hypertension research, in which investigators performed targeted RCTs within specific racial and ethnic groups that provided important information on certain treatment effects 38 . Study sponsors and journal editors can play an important role in improving the quality of reporting of race and ethnicity. The present study demonstrated that orthopaedic RCTs with government funding were significantly more likely to include reporting of race and ethnicity data, most likely as a result of federal funding regulations that require reporting of these data 12 . Similarly, journal editors and peer reviewers should be encouraged to request the reporting of race and ethnicity as an important demographic variable, and author instructions in scientific journals should emphasize this issue.
In conclusion, few orthopaedic RCTs performed in the United States reported data on race and/or ethnicity. Among trials reporting race and/or ethnicity, the enrollment of minority patients was substantially lower than their representation in the United States population. Failure to enroll minority patients into clinical trials limits the generalizability of study conclusions. Study investigators should consider measures to improve enrollment of minority patients and should attempt to provide race and ethnicity data in journal manuscripts. n
